0 TSX Venture News - November 9, 2018ALORO Mobilizes Bulldozer for Road Construction and Building of Drill PadsVANCOUVER, B.C., Nov. 09, 2018 (GLOBE NEWSWIRE) — ALORO MINING CORP. – (the “Company”) is pleased to announce that it […]Read More
0 TSX Venture News - November 9, 2018Wealth Posts Recording Link to Conference CallVANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSXV: WML; OTCQX: […]Read More
0 NYSE Companies - November 9, 2018Marine Harvest ASA (OSE:MHG) Adjustment To Conversion Price Of Convertible Bond (ISIN NO0010748742)Further to the Marine Harvest share trading on the Oslo Stock Exchange excluding a dividend of NOK 2.60 per share, […]Read More
0 TSX News - November 9, 2018Noranda Income Fund Reports Third Quarter 2018 Financial ResultsSALABERRY-DE-VALLEYFIELD, Québec, Nov. 09, 2018 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX: NIF.UN) (the “Fund”) today reported its financial results […]Read More
0 NYSE Companies - November 9, 2018TC PipeLines, LP Announces 2018 Third Quarter Financial ResultsHOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) — TC PipeLines, LP (NYSE: TCP) (the Partnership) today reported third quarter 2018 net […]Read More
0 NASDAQ Companies - November 9, 2018Fortress Biotech Reports Third Quarter 2018 Financial Results and Recent Corporate HighlightsNEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, […]Read More
0 NASDAQ Companies - November 9, 2018Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business UpdateCAMBRIDGE, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering […]Read More
0 NASDAQ Companies - November 9, 2018Tonix Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational HighlightsNew Phase 3 Trial of Tonmya® for the Treatment of PTSD to Commence First Quarter 2019 NEW YORK, Nov. 09, […]Read More
0 NASDAQ Companies - November 9, 2018Aduro Biotech Presents Preliminary Results from Ongoing Phase 1 Trials of STING agonist ADU-S100 (MIW815) in Patients with Advanced Solid Tumors or LymphomasData presented at Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting demonstrate ADU-S100 (MIW815) is well-tolerated with no dose-limiting toxicities […]Read More
0 NASDAQ Companies - November 9, 2018TG Therapeutics, Inc. Provides Business Update and Reports Third Quarter 2018 Financial ResultsInvestor Conference Call to be Held Today, Friday, November 9, 2018 at 8:30 AM ET NEW YORK, Nov. 09, 2018 […]Read More